Medigus Ltd. took additional steps in its cost reduction program, or the program. As part of the program, Mr. Gilad Mamlok, the chief financial officer of the company, will leave the company at the end of January 2017. Mr. Jeremy Starkweather, the company's VP U.S sales and marketing will leave the company at the end of December 2016.

Mr. Oded Yatzkan will be appointed as the company's chief financial officer upon Mr. Mamlok's termination. Mr. Yatzkan is the company's VP director of finance and accounting, who has served as the company's chief financial officer from September 2003 until August 2015. Mr. Chris Rowland, the chief executive officer, will assume the responsibilities of the VP U.S sales and marketing.